CNBC August 26, 2023
Annika Kim Constantino

Key Points

– It’s been 10 months since the Food and Drug Administration first announced a nationwide shortage of Adderall — and the supply strain could potentially worsen in the months ahead.

– Some experts noted they’re concerned about market conditions as children, who are commonly affected by ADHD, head back to school.

– It’s nearly impossible to know when the shortages will end — or what exactly can be done to resolve them — because of the lack of transparency in the pharmaceutical industry.

It’s been 10 months since the Food and Drug Administration first announced a nationwide shortage of Adderall — one of the most widely used medications for attention deficit hyperactivity disorder — and the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
GPUs go biological: BBB unveils Bionode, lab-grown, living neuron compute for AI applications
The Download: speaking to robots, and growing pharmaceutical mushrooms
Sofinnova closes new fund and backs a trio of new biotechs
AstraZeneca's $1 Billion Deal Highlights Growing Interest in In Vivo Cell Therapies
Pharmacy Benefit Manager Reform Keeps Getting Scuttled, Despite Bipartisan Support

Share This Article